Slover Peter T

Slover Peter T is listed in filings as Chief Financial Officer at Contineum Therapeutics, Inc. Class A Common Stock. This profile follows SEC Form 4 activity through Jan 30, 2026, including 2 public disclosures. Recent filings connect the profile to Contineum Therapeutics, Inc. Class A Common Stock (CTNM). The current snapshot covers public activity from Jan 31, 2025 to Jan 30, 2026. Reported amounts are shown as $2.7M to $1.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.